COVID-19 Vaccine
 

About the Vaccine


More than one vaccine is being developed for COVID-19. In total, the federal government has agreements to access seven different COVID-19 vaccines, including Pfizer, Moderna and AstraZeneca/Covishield.


Pfizer and Moderna Vaccines

The first vaccine approved for use in Canada on December 9, 2020 is made by Pfizer-BioNTech. Another vaccine, made by Moderna, was authorized on December 23, 2020.

For more information: Pfizer Vaccine
For more information: Moderna Vaccine


AstraZeneca/Covishield

The AstraZeneca/COVISHIELD was approved for use in Canada on Feb. 26, 2021. This vaccine has different storage requirements than the Pfizer and Moderna vaccine, which make it easier to transport and store. These vaccine doses will primarily be used to provide COVID-19 vaccines in doctors’ offices and pharmacies.

For more information: AstraZeneca/Covishield Vaccine


VISP - Vaccine Injury Support Program

The Public Health Agency of Canada has established a Vaccine Injury Support Program (VISP) in partnership with provinces and territories. While serious side effects are very rare, this program ensures anyone who experiences a serious side effect or injury because of the COVID-19 vaccine will be able to seek financial support.

The VISP is now accepting claims. People in Canada who have experienced a serious and permanent injury after receiving a Health Canada authorized vaccine, administered in Canada, on or after December 8, 2020 can submit a claim requesting financial support.

For more information on the VISP, and how to submit your claim please visit:

https://www.canada.ca/en/public-health/services/vaccination-children/safety-concerns-side-effects.html#a5

or

vaccineinjurysupport.ca

More information:

Procuring vaccines for COVID-19 - Government of Canada
Drug and vaccine authorizations for COVID-19 - Government of Canada